Evidence map›Paper›PMID 39640026›Full record

ArticleChemical science2025

Design of an abiotic unimolecular three-helix bundle.

Shuhe Wang, Johannes Sigl, Lars Allmendinger, Victor Maurizot, Ivan Huc

Abstract read
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Helical Folding of Abiotic Chiral Poly(phosphodiester)s.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  3. Article
  4. Interfacing B-DNA and DNA Mimic Foldamers.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuhe WangDepartment Pharmazie, Ludwig-Maximilians-Universität München Butenandtstraße 5-13 Munich D-81377 Germany ivan.huc@cup.lmu.de.
Johannes SiglDepartment Pharmazie, Ludwig-Maximilians-Universität München Butenandtstraße 5-13 Munich D-81377 Germany ivan.huc@cup.lmu.de.
Lars AllmendingerDepartment Pharmazie, Ludwig-Maximilians-Universität München Butenandtstraße 5-13 Munich D-81377 Germany ivan.huc@cup.lmu.de.
Victor MaurizotUniversité de Bordeaux, CNRS, Bordeaux Institut National Polytechnique, CBMN (UMR 5248), Institut Européen de Chimie Biologie 2 Rue Escarpit Pessac 33600 France.ORCID https://orcid.org/0000-0001-6104-796X
Ivan HucDepartment Pharmazie, Ludwig-Maximilians-Universität München Butenandtstraße 5-13 Munich D-81377 Germany ivan.huc@cup.lmu.de.ORCID https://orcid.org/0000-0001-7036-9696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Starting from the solid state structure of

Identifiers

PMID39640026
PMCPMC11615733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.